Martina joined Janssen as an Executive Oncology Specialist in 2017. Passionate about bicycling and supporting Multiple Myeloma research through fundraising fuels her training miles and inspires her to take on the R2V challenge of 250 miles of bicycling over 5 days. This year she is dedicating The MMRF R2V Columbia River Valley ride to: Cancer Support Community Central Ohio’s Multiple Myeloma Support Group.
At Janssen Oncology, we’re shaping the future of cancer treatment. In the process, we’re striving to change expectations of what a cancer diagnosis means. Our purpose is driven by an urgency and commitment to bringing transformational cancer solutions to the people who need them. Passionate about our work, we are driven by the personal connection many of us share with the disease. With our partners, we focus on delivering solutions that make a positive impact on human health. We are part of Janssen Biotech, Inc., and the Janssen Pharmaceutical Companies of Johnson & Johnson.About Janssen Oncology
Click below to learn more about a treatment option for multiple myeloma. If you’re also interested in getting more information from Janssen, sign up for ongoing communications.Learn More